Why the study?
Does chronic low-dose L-NAME treatment affect NO production and vasorelaxation in normotensive rats?
Population
Adult male Wistar rats (normotensive)
Comparison
L-NAME approximately 1.5 mg/kg/day in drinking… vs Control rats
Design
Preclinical
Follow-up
8 weeks
Authors
Loading...
Caution against clinical translation of low-dose L-NAME; leaves open paradoxical NO enhancement mechanisms in normotensive models.
Does chronic low-dose L-NAME treatment affect NO production and vasorelaxation in normotensive rats?
Chronic low-dose L-NAME treatment paradoxically increases NO production and vasorelaxation in normotensive rats without causing adverse cardiovascular structural changes.
Bernátová et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: